Delivery Order SPE2DB22D2206-SPE2DB26FDV52
- Not listed
- The Defense Logistics Agency awarded a $3,537.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL unit doses. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 15, 2025. This firm fixed-price, non-set-aside delivery order, which is due for completion by September 16, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,245.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pen injectors on September 17, 2025, with an ultimate completion date of September 18, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens under a firm fixed-price contract valued at $5,132.40. This non-set-aside award, with an ultimate completion date of October 27, 2025, represents a routine pharmaceutical supply transaction to support federal medical procurement needs. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections with a ceiling value of $1,088.36. This contract, issued on May 23, 2025, represents a firm fixed price delivery order with an ultimate completion date of May 27, 2025 and carries no set-aside designation. The award was made through competitive procurement processes and serves as a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $11,495.12 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pens on May 27, 2025, with completion scheduled for May 28, 2025. This competitively awarded, firm fixed-price contract requires delivery to the company's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,482.82 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pen injectors with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,187.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with a completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,759.36 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $2,978.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on October 22, 2025, with completion targeted for October 23, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's corporate office in Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDV52Delivery Order
The Defense Logistics Agency awarded a $3,265.08 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 mL pen injectors on October 30, 2025, with completion required by October 31, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and has demonstrated extensive capability in delivering brand-name and generic medications to defense and military healthcare systems. This delivery order falls under AmerisourceBergen's $999.99 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and functions as a comprehensive global pharmaceutical support vehicle. The Mounjaro delivery supports the military healthcare supply chain for diabetes management medications. AmerisourceBergen's federal contract portfolio with DLA demonstrates consistent performance across diverse therapeutic categories, and the company is positioned as a potential prime contractor under the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative, which anticipates multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/30/25 |